Heska Corporation (HSKA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

170.06+3.18 (+1.91%)

As of 3:53PM EST. Market open.

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Bearishpattern detected

Price Crosses Moving Average

View all chart patterns

Performance Outlook

Previous Close	166.88
Open	166.48
Bid	169.69 x 900
Ask	170.32 x 800
Day's Range	165.97 - 172.05
52 Week Range	50.00 - 217.17
Volume	167,397
Avg. Volume	87,200

Market Cap	1.612B
Beta (5Y Monthly)	1.61
PE Ratio (TTM)	N/A
EPS (TTM)	-1.66
Earnings Date	Feb 23, 2021
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	Sep 26, 2012
1y Target Est	208.25

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Overvalued

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

All

News

Press Releases

Research Reports

PR Newswire
Heska Announces Pricing of Upsized Public Offering of Common Stock
Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a leading provider of advanced veterinary diagnostic and specialty products, today announced the pricing of an underwritten public offering of 940,860 shares of its common stock at a price to the public of $186.00 per share, for gross proceeds of approximately $175 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by Heska. In addition, Heska has granted the underwriters a 30-day option to purchase up to an additional 141,129 shares of common stock at the public offering price, less the underwriting discounts and commissions. The size of the offering was upsized from $150 million to approximately $175 million. All of the shares of common stock to be sold in the offering will be offered by Heska.
- Norwegian Cruise Line Holdings Ltd. Announces Offering of Ordinary Shares
  GlobeNewswire
- Hayward Holdings Launches Initial Public Offering
  Business Wire
PR Newswire
Heska Announces Proposed Public Offering of Common Stock
Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a leading provider of advanced veterinary diagnostic and specialty products, today announced that it has commenced an underwritten public offering of $150 million of shares of its common stock. In addition, Heska expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock sold in the offering at the public offering price, less the underwriting discounts and commissions. All of the shares of common stock to be sold in the offering will be offered by Heska. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
- Farfetch Announces Filing of Annual Report on Form 20-F
  Business Wire
- CytoDyn Files Form S-3 to Replace Expiring Shelf Registration Statement
  GlobeNewswire
Simply Wall St.
US$209 - That's What Analysts Think Heska Corporation (NASDAQ:HSKA) Is Worth After These Results
Heska Corporation ( NASDAQ:HSKA ) just released its full-year report and things are looking bullish. Revenues and...